These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37475907)

  • 1. Retracted: MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9876019. PubMed ID: 37475907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma.
    Wu Y; Chen T; Huang Y; Li Y; Wang X
    Comput Math Methods Med; 2022; 2022():4449696. PubMed ID: 35936360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Tanaka K; Matsumoto Y; Ishikawa H; Fukumitsu N; Numajiri H; Murofushi K; Oshiro Y; Okumura T; Satoh T; Sakurai H
    J Radiat Res; 2020 Mar; 61(2):221-230. PubMed ID: 31976530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
    Hsu PK; Chien LI; Wang LC; Chou TY;
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial.
    Liu FY; Lai CH; Yang LY; Wang CC; Lin G; Chang CJ; Chang WY; Huang SH; Huang YE; Peng NJ; Hong JH; Chao A; Chou HH; Chang YC; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1812-23. PubMed ID: 27160224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.
    Bao Y; Liu S; Zhou Q; Cai P; Anfossi S; Li Q; Hu Y; Liu M; Fu J; Rong T; Li Q; Liu H
    Radiat Oncol; 2013 Oct; 8():241. PubMed ID: 24139225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy.
    Lv Y; Wang N; Liu Y; Li X; Fan L; Li M; Wang L; Yu Z; Yan Q; Guo Y; Guo S; Wei L; Shi M; Wang Z
    Diagn Pathol; 2015 Nov; 10():200. PubMed ID: 26537362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
    Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
    Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
    Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of failure patterns in patients with resectable esophageal squamous cell carcinoma receiving chemoradiotherapy.
    Shen WB; Zhu SC; Gao HM; Li YM; Su JW; Li J; Liu ZK
    J Cancer Res Ther; 2016; 12(1):62-8. PubMed ID: 27072212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis.
    Yuan Y; You J; Li X; Wang W
    Int J Gynecol Cancer; 2022 Jan; 32(1):21-27. PubMed ID: 32474447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Artificial Intelligence Algorithm-Based MRI in Evaluating the Treatment Effect of Acute Cerebral Infarction.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9794357. PubMed ID: 38094435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Local Media Image Propagation Algorithm and Its Governance in the Age of Artificial Intelligence.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9825625. PubMed ID: 37621524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.